In SNF due diligence, pharmacy costs deserve their own workstream because drugs for Medicare Part A residents are paid out of the facility's fixed daily rate, the pharmacy services agreement usually outlives a change of ownership, and Part A versus Part D billing is an active OIG audit topic. Lenders and investors should request 12 to 24 months of pharmacy invoices, the census and the agreement, then test drug cost per Part A day, contract terms, credits and payer exposure. The result is a cleaner margin figure and fewer surprises after closing.
Why does pharmacy spend matter in SNF due diligence?
Due diligence is the review a lender or investor performs before funding or buying a facility, to confirm that reported earnings and risks are what they seem. Pharmacy is easy to treat as a line item and move past. It deserves more attention for three reasons.
First, margin. Under SNF consolidated billing, the facility pays for most drugs used during a covered Part A stay out of its daily rate. Our guide to who pays for drugs during a Part A stay sets out the rules. Overbilling on that line is a recurring cost the seller may not know about.
Second, contracts. The pharmacy services agreement sets prices, fees, credits and term. Its renewal and termination clauses decide how quickly a new owner can change anything. See pharmacy services agreement terms that quietly cost you money.
Third, compliance. The OIG estimated that Part D paid up to $465.1 million in 2018 through 2020 for drugs that payment was available for under the Part A SNF benefit (OIG A-09-21-03008), and in April 2025 it opened a follow-up audit of SNF responsibility for those drugs (OIG Work Plan).
What should lenders and investors ask about pharmacy spend?
| Question | Why it matters | Document to request |
|---|---|---|
| What is facility-paid drug cost per Part A day, by month, for 24 months? | Trend and outliers, normalized for census | Invoices, census |
| What share of days are Part A? | Higher Part A mix means more facility-paid drug spend | Census by payer |
| Who is the pharmacy, and is it related to the owner or operator? | Related-party pricing needs scrutiny | Ownership chart, cost report |
| What is the agreement's term, renewal and termination notice? | Determines how fast a buyer can renegotiate | Pharmacy services agreement |
| Is there exclusivity or a minimum commitment? | Can block a switch after closing | Pharmacy services agreement |
| How are brand, generic and per diem prices set? | Drives most of the bill | Agreement pricing exhibit |
| Which fees apply: dispensing, delivery, emergency kit, IV? | Fees are where costs creep | Agreement, invoices |
| Are credits for returns tracked and received? | Unposted credits are lost cash | Credit memos, return logs |
| Has anyone tested Part A residents' drugs billed to Part D? | Compliance exposure not visible in financials | Any prior audit or review |
| Are there open pharmacy disputes or balances in dispute? | Liabilities that may transfer | Dispute log, AP aging |
What could your building recover?
Two numbers, instant estimate. No email needed.
What can public cost reports tell you?
Medicare cost reports are public. CMS publishes SNF cost report data through its Healthcare Cost Report Information System files (CMS cost reports). For cost reporting periods ending on or after September 30, 2025, SNFs file on Form CMS-2540-24. Its instructions place routine drugs and pharmacy personnel on Worksheet A line 11 (Pharmacy) and drugs traceable to individual patients on line 41 (Drugs Charged to Patients) (CMS Pub. 15-2, Chapter 49).
Cost reports also capture related-party transactions. Costs of services from related organizations are generally allowable at the related organization's cost (42 CFR 413.17), and the form includes a worksheet for them (Worksheet A-8-1).
Use cost reports for trend and peer comparison. They are annual, aggregated and filed months after year end. They cannot show which invoice lines are wrong, or whether Part A drugs were billed to Part D.
What happens to the pharmacy contract at a change of ownership?
Two different things transfer. Under Medicare rules, when a change of ownership occurs, the existing provider agreement is automatically assigned to the new owner and remains subject to the terms under which it was originally issued (42 CFR 489.18). Ask counsel what that means for any Medicare billing issues from before closing.
The pharmacy services agreement is a private contract. Whether it transfers, and on what terms, depends on its assignment, change-of-control and termination clauses. Read those before you sign the purchase agreement, not after. Our guide to switching LTC pharmacy providers covers the practical side. This article is general information, not legal advice.
How do you test pharmacy spend inside a diligence window?
- Request the data early: 12 to 24 months of invoice line detail, census with daily payer status, and the full agreement with all amendments.
- Sign a business associate agreement with any outside reviewer before data moves, and use de-identified resident IDs where possible.
- Rebuild drug cost per Part A day from invoices and census, by month.
- Test payer status on every line for residents in Part A stays.
- Test charges after discharge, death and leave, and match credits.
- Test fees and prices against the agreement.
- Quantify recurring overbilling as an annual figure and adjust normalized earnings.
- List the exposure items separately for counsel and the buyer's compliance team.
Illustrative example. If testing shows $3,000 a month of recurring overbilling at one building, normalized annual costs are $36,000 too high on the seller's current terms. Whether that is upside for the buyer or a risk depends on whether the agreement allows it to be fixed.
For how we support investors and lenders, see owners, investors and lenders.
Free · 48 hours · no integration
Get a free 48-hour pharmacy audit
- Send three files: invoices, census, contract
- See overbilling and Part A exposure, line by line
- BAA signed before any data moves
Frequently asked questions
What pharmacy documents should be requested in SNF due diligence?
Pharmacy invoices with line detail for 12 to 24 months, the census with daily payer status, the pharmacy services agreement with every amendment, credit memos, and any prior pharmacy audits. Add the most recent Medicare cost report for trend context.
Does the pharmacy contract transfer when a nursing home is sold?
It depends on the agreement's assignment and change-of-control clauses. The Medicare provider agreement is assigned automatically at a change of ownership, but the pharmacy contract is a private agreement. Have counsel review it before closing.
How big is pharmacy spend for a nursing home?
It varies with size, acuity and Part A mix. As a planning estimate only, Pennywell assumes $250,000 to $500,000 a year in facility-paid drug spend per building. Test the actual figure from invoices; see how much nursing homes spend on pharmacy.
What is the biggest pharmacy risk for an SNF buyer?
Payer misbilling: drugs for Part A residents billed to Part D or Medicaid. It is an active OIG audit topic and does not appear in the financial statements.
Can a buyer fix a costly pharmacy contract after closing?
Often, but timing depends on the agreement. Check the renewal date, the notice deadline and any termination-for-cause terms. Documented overbilling from an invoice review gives the buyer leverage in that conversation; see questions to ask before you renew.
Get the 48-hour first look
Diligence windows are short. Send three months of invoices, the census and the pharmacy services agreement, under a BAA, and we report overbilling and Part A exposure within 48 hours. Request the free 48-hour audit or size the opportunity with the savings calculator.